Secretases as targets for the treatment of Alzheimer's disease

Author： Citron M.  

Publisher： Elsevier

ISSN： 1357-4310

Source： Molecular Medicine Today, Vol.6, Iss.10, 2000-10, pp. : 392-397

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Presenilins as therapeutic targets for the treatment of Alzheimer's disease

By Golde T.E.   Younkin S.G.  

Trends in Molecular Medicine, Vol. 7, Iss. 6, 2001-06 ,pp. : 264-269

Elsevier

Access to resources Recommend Favorite

A Rationale for Curcuminoids for the Prevention or Treatment of Alzheimer's Disease

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 15-25

Bentham Science Publishers

Access to resources Recommend Favorite

Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease

By Poirier J.  

Trends in Molecular Medicine, Vol. 9, Iss. 3, 2003-03 ,pp. : 94-101

Elsevier

Access to resources Recommend Favorite

Improved activity and mental function related to proper antiasthmatic treatment in elderly patients with Alzheimer's disease

By Bozek Andrzej   Jarzab Jerzy  

Allergy and Asthma Proceedings, Vol. 32, Iss. 5, 2011-09 ,pp. : 341-345

OceanSide Publications, Inc

Access to resources Recommend Favorite

Alzheimer’s Disease

By  

Comprehensive Therapy, Vol. 33, Iss. 2, 2007-06 ,pp. : 58-64

Humana Press, Inc

Access to resources Recommend Favorite